A detailed history of Silvercrest Asset Management Group LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 534,825 shares of JNJ stock, worth $83 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
534,825
Previous 546,163 2.08%
Holding current value
$83 Million
Previous $79.8 Million 8.58%
% of portfolio
0.61%
Previous 0.59%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $1.65 Million - $1.9 Million
-11,338 Reduced 2.08%
534,825 $86.7 Million
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $78.9 Million - $86.2 Million
-546,163 Reduced 50.0%
546,163 $79.8 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $75 Million - $82 Million
519,596 Added 90.72%
1,092,326 $160 Million
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $325,185 - $340,940
-2,095 Reduced 0.36%
572,730 $90.6 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $2.07 Million - $2.26 Million
-14,235 Reduced 2.42%
574,825 $90.1 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $2.31 Million - $2.58 Million
-14,815 Reduced 2.45%
589,060 $91.7 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $2.16 Million - $2.32 Million
-13,993 Reduced 2.26%
603,875 $100 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $1.53 Million - $1.83 Million
-10,159 Reduced 1.62%
617,868 $95.8 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $870,366 - $976,799
-5,433 Reduced 0.86%
628,027 $111 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $619,991 - $689,895
-3,843 Reduced 0.6%
633,460 $103 Million
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $3 Million - $3.32 Million
17,853 Added 2.88%
637,303 $113 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $541,787 - $615,275
-3,426 Reduced 0.55%
619,450 $110 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $152,031 - $168,684
-975 Reduced 0.16%
622,876 $107 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $3.48 Million - $3.87 Million
-21,554 Reduced 3.34%
623,851 $101 Million
Q2 2021

Aug 16, 2021

SELL
$159.48 - $171.07 $196,479 - $210,758
-1,232 Reduced 0.19%
645,405 $106 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $1.31 Million - $1.46 Million
-8,569 Reduced 1.31%
646,637 $106 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $464,665 - $533,360
-3,389 Reduced 0.51%
655,206 $103 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $1.19 Million - $1.3 Million
-8,479 Reduced 1.27%
658,595 $98.1 Million
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $693,126 - $836,799
5,381 Added 0.81%
667,074 $93.8 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $1.06 Million - $1.48 Million
-9,581 Reduced 1.43%
661,693 $86.8 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $21,420 - $24,601
168 Added 0.03%
671,274 $97.9 Million
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $1.99 Million - $2.23 Million
-15,666 Reduced 2.28%
671,106 $86.8 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $1.1 Million - $1.21 Million
8,389 Added 1.24%
686,772 $95.7 Million
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $149,732 - $166,489
1,191 Added 0.18%
678,383 $94.8 Million
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $2 Million - $2.41 Million
-16,305 Reduced 2.35%
677,192 $87.4 Million
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $431,852 - $507,509
-3,552 Reduced 0.51%
693,497 $95.8 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $508,047 - $560,638
-4,255 Reduced 0.61%
697,049 $84.6 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $355,659 - $421,162
2,843 Added 0.41%
701,304 $89.9 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $189,744 - $207,674
1,446 Added 0.21%
698,461 $97.6 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $90.2 Million - $94.4 Million
697,015
697,015 $90.6 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.